Epigenetic Mechanisms of Neurodegeneration in Huntington's Disease

Abstract

Huntington's disease (HD) is an incurable and fatal hereditary neurodegenerative disorder of mid-life onset characterized by chorea, emotional distress, and progressive cognitive decline. HD is caused by an expansion of CAG repeats coding for glutamine (Q) in exon 1 of the huntingtin gene. Recent studies suggest that epigenetic modifications may play a key role in HD pathogenesis. Alterations of the epigenetic "histone code" lead to chromatin remodeling and deregulation of neuronal gene transcription that are prominently linked to HD pathogenesis. Furthermore, specific noncoding RNAs and microRNAs are associated with neuronal damage in HD. In this review, we discuss how DNA methylation, posttranslational modifications of histone, and noncoding RNA function are affected and involved in HD pathogenesis. In addition, we summarize the therapeutic effects of histone deacetylase inhibitors and DNA binding drugs on epigenetic modifications and neuropathological sequelae in HD. Our understanding of the role of these epigenetic mechanisms may lead to the identification of novel biological markers and new therapeutic targets to treat HD.

Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target

“…Epigenetic modification is involved in the regulation of large number of genes regulation, and it has been suggested that the microRNAs, DNA methylation of specific gene promoters and histone modifications (acetylation, phosphorylation and methylation) are regarded as the most popular epigenetic genes [51,52]. Furthermore, a growing body of recent publications indicate that epigenetics plays a crucial role in controlling HIF-1a activity [53,54].…”

Elevated Global DNA Methylation Is Not Exclusive to Amyotrophic Lateral Sclerosis and Is Also Observed in Spinocerebellar Ataxia Types 1 and 2

“…On the other hand, the huntingtin protein has been shown to have a significant impact on many epigenetic marks, ranging from various histone modifications to DNA methylation [36-38]. Aberrant DNA methylation has also been reported both downstream and upstream of the expansion in frataxin [39], with hypermethylation especially in the first intron showing a direct correlation with the expansion size and the age of onset [40].…”

Epigenetics of Brain Disorders: The Paradigm of Alzheimer ’s Disease

“…Epigenetic changes are also determinant in several neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease or Huntington's disease [9,15,16,31,32]. …”

“…In Western countries, AD is the most prevalent form of dementia (45-60%), followed by vascular dementia (VD) (30-40%), and mixed dementia (10-20%), which in people older than 85 years of age may account for over 80% of the cases. The different forms of dementia pose several challenges to our society and the scientific community: (i) they represent an epidemiological problem, and a socio-economic, psychological and family burden; (ii) most of them have an obscure/ complex pathogenesis; (iii) their diagnosis is not easy and lacks specific biomarkers; and (iv) their treatment is difficult and inefficient [2,3,31,34,35]. In terms of economic burden, approximately 10-20% of direct costs are associated with pharmacological treatment, with a gradual increase in parallel with the severity of the disease.…”